Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.42 |
| ▸ | AVPR2 | P30518 | 9/20 | 0.41 |
| ▸ | AVPR1A | P37288 | 4/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | EIF2AK3 | Q9NZJ5 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | OXTR | P30559 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6667068 | 0.91 | MAPT (0.43) | MAPTTP53NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL6799258 | 0.90 | SMO (0.49) | MAPTTP53LMNAALDH1A1 | |
| SCHEMBL6668503 | 0.88 | EIF2AK3 (0.51) | MAPTTP53NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL6804824 | 0.87 | CASP3 (0.49) | MAPTTP53NPC1RAB9ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL6664580 | 0.87 | EIF2AK3 (0.50) | MAPTTP53NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL6803455 | 0.86 | MAPT (0.44) | MAPTTP53NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL6804843 | 0.85 | MAPT (0.46) | MAPTTP53NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL6801575 | 0.85 | MAPT (0.53) | MAPTTP53NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL6804764 | 0.84 | MAPT (0.44) | MAPTTP53NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL6803357 | 0.84 | EIF2AK3 (0.46) | MAPTTP53NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040157866-A1 | Amide compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040157866-A1 | Amide compounds | APOB, NR1H2, NR1H3 | MAPT 4047/4885TP53 4791/4885NPC1 40/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.